Compare EVO & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | ELVR |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | Germany | Australia |
| Employees | 4553 | 230 |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 941.8M |
| IPO Year | N/A | N/A |
| Metric | EVO | ELVR |
|---|---|---|
| Price | $2.90 | $90.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 51.5K | ★ 80.5K |
| Earning Date | 04-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $90.73 |
| Revenue Next Year | $10.05 | $42.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $15.55 |
| 52 Week High | $4.42 | $101.50 |
| Indicator | EVO | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 55.48 |
| Support Level | $2.88 | $77.29 |
| Resistance Level | $3.78 | $101.50 |
| Average True Range (ATR) | 0.08 | 3.34 |
| MACD | -0.01 | -1.18 |
| Stochastic Oscillator | 43.11 | 52.29 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.